The Option
Netflix issued a flat denial Tuesday after Lionsgate shares surged 14% on acquisition speculation — but the denial doesn't close the story. Lionsgate is positioned as a pure-play acquisition target following its May 2025 separation from Starz, with a stock that's climbed from ~$6 to over $16 since the split. That success raises the acquisition floor at a moment when Hollywood consolidation is accelerating fast. This episode breaks down what the Netflix denial actually signals, what Lionsgate's IP slate is worth to a strategic buyer, and where the broader M&A wave is heading. Key Takeaways: * Lionsgate shares surged 14% Tuesday on Netflix merger speculation before giving back 3.5% after-hours on Netflix's denial. * Netflix walked away from Warner Bros. Discovery with a $2.8 billion breakup fee and has also denied interest in Imax and did not bid for Roku. * Lionsgate Studios shares have risen from ~$6 at the May 2025 Starz separation to over $16 — a higher stock price raises the acquisition cost and historically Lionsgate has asked more than the market was ready to pay. * Key Lionsgate IP in play: Michael is approaching $1 billion globally, The Hunger Games: Sunrise on the Reaping hits this fall, and Mel Gibson's two-part The Resurrection of the Christ is staged for spring 2027 and 2028. * Library rights entanglements remain a due diligence risk that buyers have cited privately — Lionsgate disputes the characterization but it historically compresses deal price. * Netflix confirmed separately it is not pursuing Imax; Raine is fielding interest from strategic buyers and others for the big-screen exhibitor. * Closed or announced major deals in the current consolidation wave: Paramount-Skydance, Paramount-WBD, Charter-Cox, Fox-Roku; Nexstar-Tegna faces state AG litigation. * Netflix has reportedly expressed interest in Sony Pictures, which is not for sale — Sony Group has reaffirmed SPE is central to its corporate strategy. Lionsgate remains the most legible remaining standalone acquisition target in Hollywood. The denial from Netflix is data, not resolution. For agents, producers, and executives whose deal universe depends on knowing who the next buyer is — the rights entanglement question is the variable to track. How that shakes out in due diligence will set the ceiling on any eventual deal price. Watch the fall slate performance and any movement from private equity or strategic buyers on Imax as a parallel signal for where appetite is forming. Subscribe to The Option for daily updates on the business behind the business.
83 jaksot
Kommentit
0Ole ensimmäinen kommentoija
Rekisteröidy nyt ja liity The Option-yhteisöön!